Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05249348 · ClinicalTrials.gov registry record · Phase 1
Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteers
A Phase 1 study, sponsored by PMV Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT05249348 is a Phase 1 study that has completed, run by PMV Pharmaceuticals. The registered enrollment target is 34 participants.
The verdict
NCT05249348, a Phase 1 study, has completed, sponsored by PMV Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
This is a 2-part Phase 1 cross-over study to assess the effects of food on the pharmacokinetics of PC14586 in healthy volunteers. The pharmacokinetics of PC14586 at a clinically relevant dose in Japanese participants will also be studied.
Interventions
- DRUG PC14586
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-12-20 |
| Est. Completion | 2022-06-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05249348
The ClinicalTrials.gov registry entry for NCT05249348 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PMV Pharmaceuticals, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PC14586 is the first listed.
NCT05249348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05249348 about?
NCT05249348 is a clinical study titled "Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteers". This is a 2-part Phase 1 cross-over study to assess the effects of food on the pharmacokinetics of PC14586 in healthy volunteers. The pharmacokinetics of PC14586 at a clinically relevant dose in Japanese participants will also be studied.
What is the current status of trial NCT05249348?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2021-12-20. Estimated completion is 2022-06-09.
What interventions are being tested in trial NCT05249348?
The interventions under investigation include: PC14586 (DRUG).
Who is sponsoring clinical trial NCT05249348?
This trial is sponsored by PMV Pharmaceuticals, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.